BackWest Pharmaceutical Services Overview
West Pharmaceutical Services, Inc.

West Pharmaceutical Services Target Price

See West Pharmaceutical Services's analyst price targets ($410) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$364.98

Average Target Price

$406.5011.4% upside

8 analysts in the last 4 months

High: $447 | Low: $365

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-22Morgan StanleyKallum Titchmarsh$4009.6% upsideOpen
2026-09-09UBS$41513.7% upsideOpen
2026-07-27Evercore ISI$42516.4% upsideOpen
2026-07-13BNP Paribas$44722.5% upsideOpen
2026-07-09Morgan Stanley$3650% upsideOpen
2026-07-06Evercore ISIDaniel Markowitz$41012.3% upsideOpen
2026-07-02KeyBanc$3906.9% upsideOpen
2026-06-09BarclaysLuke Sergott$4009.6% upsideOpen
2026-04-27Morgan Stanley$31513.7% downsideOpen
2026-04-27Barclays$31015.1% downsideOpen
2026-02-13UBSDan Leonard$3406.8% downsideOpen
2026-02-13Deutsche Bank$31513.7% downsideOpen
2026-02-13BarclaysLuke Sergott$26527.4% downsideOpen
2026-02-10JefferiesDavid Windley$29519.2% downsideOpen
2026-02-03Evercore ISIDaniel Markowitz$32012.3% downsideOpen
2025-12-01Morgan Stanley$28521.9% downsideOpen
2025-10-27Barclays$32511% downsideOpen
2025-10-24UBSDan Leonard$3552.7% downsideOpen
2025-10-24Deutsche BankJustin Bowers$3455.5% downsideOpen
2025-10-23Evercore ISIDaniel Markowitz$3906.9% upsideOpen
2025-10-07Evercore ISI$3504.1% downsideOpen
2025-10-02Barclays$27524.7% downsideOpen
2025-09-15Redburn PartnersJamie Clark$31114.8% downsideOpen
2025-06-24BarclaysLuke Sergott$24532.9% downsideOpen
2024-11-19JefferiesDavid Windley$3937.7% upsideOpen
2024-02-07JefferiesDavid Windley$53646.9% upsideOpen
2022-12-14Deutsche Bank$25031.5% downsideOpen
2022-11-30UBS$25031.5% downsideOpen

West Pharmaceutical Services (WST) FAQ

West Pharmaceutical Services posts a target price of $410. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $410 for WST means covering analysts, on average, see the stock 11.4% upside of $364.98 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for WST's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; West Pharmaceutical Services's other metric pages and overview cover the third.

Judging West Pharmaceutical Services against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $410 here, then scan peer and history charts to see if the gap is persistent.